InMode (INMD) Expected to Release Earnings on Thursday

InMode (NASDAQ:INMDGet Free Report) is anticipated to issue its Q2 2026 results before the market opens on Thursday, July 23rd. Analysts expect the company to post earnings of $0.3327 per share and revenue of $93.0410 million for the quarter. Investors are encouraged to explore the company’s upcoming Q2 2026 earning report page for the latest details on the call scheduled for Wednesday, August 5, 2026 at 9:30 AM ET.

InMode (NASDAQ:INMDGet Free Report) last released its quarterly earnings data on Wednesday, May 6th. The healthcare company reported $0.25 earnings per share for the quarter, missing analysts’ consensus estimates of $0.30 by ($0.05). InMode had a return on equity of 13.47% and a net margin of 23.27%.The business had revenue of $82.02 million during the quarter, compared to analysts’ expectations of $79.84 million. During the same period last year, the company earned $0.31 earnings per share. The firm’s revenue was up 5.3% compared to the same quarter last year.

InMode Price Performance

Shares of InMode stock opened at $15.36 on Wednesday. InMode has a 1 year low of $12.72 and a 1 year high of $16.74. The firm’s 50-day moving average is $14.18 and its two-hundred day moving average is $14.19. The stock has a market cap of $882.89 million, a price-to-earnings ratio of 11.29 and a beta of 1.91.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on INMD shares. Robert W. Baird lowered their price target on shares of InMode from $17.00 to $14.00 and set a “neutral” rating for the company in a research report on Thursday, May 7th. Barclays set a $19.00 price objective on shares of InMode and gave the company an “overweight” rating in a report on Thursday, May 7th. One research analyst has rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $16.00.

View Our Latest Stock Analysis on INMD

Institutional Investors Weigh In On InMode

Institutional investors have recently added to or reduced their stakes in the stock. Quadrant Capital Group LLC raised its holdings in InMode by 127.8% in the fourth quarter. Quadrant Capital Group LLC now owns 1,945 shares of the healthcare company’s stock worth $29,000 after purchasing an additional 1,091 shares in the last quarter. Advisory Services Network LLC purchased a new stake in shares of InMode during the third quarter valued at about $37,000. Deutsche Bank AG boosted its holdings in shares of InMode by 35.9% in the 4th quarter. Deutsche Bank AG now owns 3,927 shares of the healthcare company’s stock valued at $58,000 after buying an additional 1,037 shares in the last quarter. Parallel Advisors LLC boosted its holdings in shares of InMode by 113.3% in the 4th quarter. Parallel Advisors LLC now owns 4,318 shares of the healthcare company’s stock valued at $63,000 after buying an additional 2,294 shares in the last quarter. Finally, Brooklyn Investment Group purchased a new position in shares of InMode in the 4th quarter worth approximately $154,000. Institutional investors own 68.04% of the company’s stock.

InMode Company Profile

(Get Free Report)

InMode Ltd. (NASDAQ:INMD) is a medical technology company headquartered in Israel that develops, manufactures and markets devices for aesthetic and medical treatments. The company specializes in energy-based technologies, primarily radiofrequency platforms, designed to deliver minimally-invasive and non-invasive procedures.

InMode’s product portfolio encompasses a range of modular systems targeting body contouring, facial rejuvenation, skin tightening and other cosmetic applications. Key offerings include devices built on proprietary radiofrequency and radiofrequency-assisted lipolysis, enabling physicians to perform treatments such as tissue coagulation, skin resurfacing and subdermal volumizing with reduced downtime.

The company distributes its technologies through direct sales operations and distribution partners, serving medical professionals across multiple geographies including North America, Europe, Asia Pacific and Latin America.

Featured Articles

Earnings History for InMode (NASDAQ:INMD)

Receive News & Ratings for InMode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InMode and related companies with MarketBeat.com's FREE daily email newsletter.